CClinicalTrials.gg
Not yet recruitingNCT06081842Updated Oct 13, 2023

Strengthening Contraceptive Counseling Services: Research Protocol for a Multi-phase Complex Intervention in Pakistan and Nigeria

An interventional study of Contraceptive counseling strengthening intervention package in Contraception, Empowerment and Decision Making, sponsored by World Health Organization. Not yet recruiting. Open to female participants aged 15 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-13.

Sponsored by World Health Organization · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Nov 2025, 11 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
7,920
Allocation
Randomized
Ages
15 Years to 49 Years
Sex
Female
01

Study summary

High-quality contraceptive counseling can strengthen global efforts to reduce the unmet need for and suboptimal use of modern contraceptives. This study aims to identify a package of contraceptive counseling interventions for Pakistan and Nigeria designed to strengthen existing contraceptive services and determine its effectiveness in increasing clients' level of decision-making autonomy and meeting their contraceptive needs.

Read the detailed description

The research will be a multi-intervention, three-arm, single-blinded, parallel, cluster RCT done in selected primary health centers (clusters) in Pakistan and in Nigeria. Centers will be randomly allocated to the three study arms in matched ratios (1:1:1) on the basis of the number of monthly family planning encounters, the number of available contraceptive types, the ratio of health workers per population in the clinic coverage zone, the location in urban or rural settings, and selected district-level variables that may have an influence on the study outcomes, including the unmet need for family planning, the level of literacy among women, and household income quartiles. Only data analysts will be masked to trial-arm allocation. Service providers skilled in family planning services will implement the clinical components of the contraceptive counseling package. The cluster RCT design is justified by the fact that some of the components of the intervention package to be identified in the intervention design phase will not be delivered directly to individual participants but only applied at the level of the health center, such as refresher training of service providers.

The two-part formative phase first uses participatory approaches to identify the perspectives of clients, including young people and providers, to ensure research contextualization and address each interest group's needs and priorities; clinical observations of client-provider encounters to document routine care form the second part. The design workshop of the third phase will result in the development of a package of contraceptive counseling interventions. In the fourth and experimental phase, a multi-intervention, three-arm, single-blinded, parallel cluster randomized-controlled trial will compare routine care (arm 1) with the contraceptive counseling package (arm 2) and the same package combined with wider method availability (arm 3). The fifth and reflective phase aims to analyze the package's cost-effectiveness and identify implementation barriers and enablers. The primary outcomes are clients' level of decision-making autonomy and met need for modern contraceptives.

02

Conditions studied

  • Contraception
  • Empowerment
  • Decision Making

Keywords

  • Family Planning, Counselling, choice
03

In context

Lead sponsor

World Health Organization is the lead sponsor of 10 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Client comes to the family planning clinic with the intention to 1.a. use contraception for the first time in her life (new user), or 1.b. switch from a contraceptive method to another one (switching user), or 1.c. resume a method after not using any in the prior three months (lapse user), or 1.d. discontinue a modern method (discontinuing user);
  2. Client is not coming for the resupply of a currently used method, such as pills or injectables;
  3. Client has the intention to continue her follow-up at the health center during the duration of study follow-up;
  4. Client does not participate in another study; and
  5. Client provides informed consent.

Exclusion criteria

Exclusion Criteria:

Not willing to participate in the complete duration of the trial

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
7,920 participants (estimated)

Study arms

  • Active comparator
    Arm 1. Routine care

    Routine contraceptive counseling and routine method availability

    Other: Contraceptive counseling strengthening intervention package

  • Experimental
    Arm 2. Package of contraceptive counseling interventions

    The implementation package will be co-designed by providers and clients during the formative and research design phases

    Other: Contraceptive counseling strengthening intervention package

  • Experimental
    Arm 3. Expanded methods

    Routine care with the contraceptive counseling package combined with wider method availability as recommended by national policies.

    Other: Contraceptive counseling strengthening intervention package

Interventions

  • OtherContraceptive counseling strengthening intervention package

    Development of contraceptive counseling strengthening intervention package that strengthens existing family planning services and is effective, safe, sustainable, scalable, and culturally appropriate.

06

What researchers measure

Primary outcomes

  1. Change in clients' decision-making autonomy

    Person-Centered Contraceptive Counseling scale (PCCC). On a scale of 1-5, with score range between 4 to a maximum score of 20, with the highest possible score on a scale will be considered good.

    Time frame: Through study completion, an average of 1 year

  2. Change in clients' met need for family planning

    Number of participants who want to avoid a pregnancy and are using a contraceptive method / all participants

    Time frame: Through study completion, an average of 1 year

Secondary outcomes

  1. Change in modern contraceptive prevalence

    Number of participants using a modern contraceptive / all participants

    Time frame: 6 months and 12 months post enrollment

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — (i) use of a controlled access approach, such as upon reasonable request from the World Health Organization; (ii) the trial will seek consent for sharing Individual Participant Data (IPD) from trial participants with adequate assurance that patient privacy and confidentiality will be maintained

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06081842
Lead sponsor
World Health Organization
Collaborators
Jinnah Sindh Medical University, University of Ibadan
Responsible party
Moazzam Ali (Medical officer / Epidemiologist, World Health Organization) — Principal investigator
First posted
Oct 13, 2023
Start date
Nov 2023 (estimated)
Primary completion
Nov 2025 (estimated)
Completion
Jun 2026 (estimated)
Last update
Oct 13, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion